Quantum Biopharma Ltd (HUGE) Return on Equity ROE from the third quarter 2025 to third quarter 2024 and annually, average high and low, overall ranking from Sep 30 2025 to 0 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Quantum Biopharma Ltd   (NASDAQ: HUGE)

Quantum Biopharma Ltd 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Quantum Biopharma Ltd in the third quarter 2025?
Quantum Biopharma Ltd recorded a cumulative net loss of $-37 million during 12 months ending in the third quarter 2025, resulting in a negative return on equity (ROE) of -780.93%.

Within the Major Pharmaceutical Preparations industry 308 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2025 from 3689 to 3949.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 0
III. Quarter
Y / Y Equity Change -51.13 % -51.08 % -79.94 % -60.67 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -37 -37 -30 -24 -27
Return On Equity (TTM) -780.93 % -599.01 % -374.64 % -233.6 % -230.4 %
HUGE's Total Ranking # 3949 # 3689 # 0 # #
Equity (TTM) in Millions 5 8 2 5 10
Seq. Equity Change -32.03 % 266.71 % -54.8 % -56.62 % -31.97 %
Seq. Net Income Change - - - - -

Back to HUGE Management Effectiveness >> HUGE's 5 Years Annual ROE >> Compare HUGE ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 309
Sector # 676
Overall # 3949

Return On Equity Statistics
High Average Low
-65.19 %
-104.3 %
-138.68 %
(Dec 31 2021)   (Dec 31 2023)





HUGE Annual Return On Equity (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020
Total Equity in Millions 5 10 13 31 54
Y / Y Equity Change -51.13 % -19.13 % -57.73 % -43.58 % 49.09 %
Net Income in Millions -14 -18 -24 -35 -32
Y / Y Net Income Change - - - - -
Return On Equity -278.34 % -171.47 % -182.87 % -115.53 % -58.75 %

Back to HUGE Management Effectiveness >> HUGE's 5 Years Annual ROE >> Compare HUGE ROE to its Competitors




More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
HUGE's' Return on Equity at Yahoo Finance
HUGE's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for HUGE's Competitors
Subscribers only: Roe for Quantum Biopharma Ltd 's Suppliers
Subscribers only: Return On Equity for HUGE's Customers




Companies with similar Return On Equity at Sep 30 2025, within Healthcare Sector ROE

Date modified: 2026-06-23T19:22:26+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.